MF houses
Aug 20260no change m/m
No tracked fund house held SMSPHARMA in Aug 2026.
AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure)
0 fund houses →
SMS Pharmaceuticals Limited
₹475.00NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 10 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
0.00%▼ −0.00 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
0.65%
as of 30 Jun 2026
Fund houses holding
0no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
17.99%
as of 30 Jun 2026
What changed
No tracked fund house held SMSPHARMA in Aug 2026 (20 AMCs tracked).
Named FPIs at 1% or more
as of 30 Jun 20260.65%
FPI category I + II, % of total shares · 0 named at 1% or more
No FPI held 1% or more of SMSPHARMA on 30 Jun 2026.
Shareholding pattern as of 30 Jun 2026, filed 10 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly
Insider and promoter
29 Jun 2026 to 26 Sep 20263▼ net −50 sh
disclosed transactions · equity bought 3,000 sh, sold 3,050 sh
Latest: NVV Satyanarayana (Designated Person), Sell 1,000 Equity worth ₹4,80,500, 15 Sep 2026, Market Sale.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)
Bulk and block deals
25 Sep 2026No bulk or block deals in SMSPHARMA on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily
Promoter pledge
as of 30 Jun 202617.99%
of promoter holding · 12.24% of total shares
Promoters had pledged 1.15 cr of their 6.37 cr shares on 30 Jun 2026; 1.15 cr encumbered in all (pledge, NDU and other).
Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly
SLBM borrowing
25 Sep 2026NSE listed no SLBS open position for SMSPHARMA on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in SMSPHARMA on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily
MTF book
24 Sep 202612.28 lakh sh▲ +29,345 vs 23 Sep 2026
percentile 83 of 29 days collected · ₹51.0 cr financed
12.28 lakh shares, 1.31% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 83 of 29 days collected.
NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily
Delivery
25 Sep 202638.5%▲ +1.1 pp vs 20-day average
20-day average 37.4% · percentile 33 of 30 days collected
38.5% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 37.4%; that day sits at percentile 33 of 30 days collected.
NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily
Red flags
25 Sep 2026No F&O
SMSPHARMA has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed SMSPHARMA under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.
NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily